By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences is surrendering more than 51,000 square feet of space under a new lease agreement coverings its offices and facilities, according to a regulatory document filed late on Thursday.

The company also disclosed it is behind in its rent payment.

Under the terms of the new lease, the Cambridge, Mass.-based firm has surrendered and vacated 34,543 square feet in office space and will be surrendering an additional 16,782 square feet of space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.